+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-13Number of Pages: 187

Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application - Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User - Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Oligonucleotide Synthesis Market: Snapshot 

Entry of new players in the global oligonucleotide synthesis market has heated up competition. Players wanting to grow their market shares have mostly resorted to cutting down prices to draw more customers. This has also put a downward pressure on prices and subsequently many prominent vendors have been forced to strategically cut down certain service and product arms and focus on a niche sector.

Currently, Thermo Fisher Scientific holds a dominant position in the global oligonucleotide synthesis market because of its diverse product portfolio and strong outreach. Sigma-Aldrich Corporation comes in the second position in terms of market share. 

The global oligonucleotides synthesis market has been on a sustained growth trajectory on account of the rapidly growing biotechnology and life sciences sectors, coupled with the increasing uptake of the increasing applications of oligonucleotides in research and diagnostic fields. Pharmaceutical and biotechnology companies and research and diagnostic laboratories involved in drug discovery and development, along with diagnostic devices and tests, for the treatment of chronic diseases and oligonucleotides are also serving to stoke growth in the market. 

A report by Transparency Market Research forecasts the global oligonucleotide synthesis market to expand at a strong 11.2% CAGR from 2017 to 2025 to attain a value of US$4.189 bn by 2025 from US$1.65 bn in 2016. 

oligonucleotide synthesis market

Synthesized Oligonucleotides Lead Market on Account of Different Customizations Offered by Manufacturers 

Depending upon the type of products, the global oligonucleotide synthesis market can be divided into reagents and consumables, equipment, and synthesized oligonucleotides. Among them, the synthesized oligonucleotides segment leads the market with a dominant share because of the increasing number of manufacturers offering various customizations and rising applications of ready to use synthesized oligonucleotides in therapeutics. 

The two kinds of commercially used synthesized oligonucleotide are DNA oligonucleotides and RNA oligonucleotides. Locked Nucleic acid (LNA) and Bridged Nucleic Acid (BNA) are the other types of synthesized oligonucleotides that find application in research. 

Presence of Numerous Small Companies Makes China Key Region in Asia Pacific 

From a geographical perspective, the global oligonucleotide synthesis market is dominated by North America. It is expected to retain its leading share, albeit decreasing it slightly, to account for 33.3% of the market. Strongly supporting growth in the North America market is the growing number of pharmaceutical companies leveraging oligonucleotides in therapeutics, research and diagnostics. Increasing number of genetic diseases in the region and the resultant demand for researchers to develop newer and advanced drugs to treat them is also expected to drive the market in the region. 

Europe is another key region in the global oligonucleotide synthesis market and by 2025, it is slated to account for 26.6% share in revenue in the market on the back of considerable thrust on developing newer and sophisticated technologies for building new molecules of oligonucleotides for therapeutic use. Start-up companies with new technologies and rich patent portfolios, are predicted to contribute to the market significantly. 

In terms of growth rate, Asia Pacific will likely surpass all other regions by clocking a healthy 12.5% CAGR between 2017 and 2025. China is a major driver of growth in the region on account of being home to numerous of small companies providing reagents and consumables for oligonucleotide synthesis. Besides China, India and Japan are also major contributors to the market because of bettering health care infrastructure, increasing private and public investment in life sciences research, and diagnostics advancements in disease treatment. 

Prominent participants in the global oligonucleotide synthesis market are Thermo Fisher Scientific, GE Healthcare, DNA Technologies, BioAutomation, Applied Biosystems, GeneDesign, Inc., Eurofins Genomics, Integrated Kaneka Eurogentec S.A., Sigma-Aldrich Corporation, and Agilent Technologies.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oligonucleotide Synthesis Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Oligonucleotide Synthesis Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Value Chain Analysis
     4.9. Market Outlook
     4.10. Applications of Oligonucleotides
     4.11. PEST Analysis
     4.12. Pipeline Analysis

5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Product Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast by Product Type, 2015–2025
            5.4.1. Reagents & Consumables
            5.4.2. Equipment
            5.4.3. Synthesized oligonucleotides
                     5.4.3.1. DNA Oligonucleotides  
                     5.4.3.2. RNA Oligonucleotides 
                     5.4.3.3. Others
     5.5. Market Attractiveness by Product Type 

6. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Application 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast by Application, 2015–2025
            6.4.1. Research
                     6.4.1.1. Polymerase Chain Reaction 
                     6.4.1.2. Next Generation Sequencing 
                     6.4.1.3. Others
            6.4.2. Therapeutics 
                     6.4.2.1. Antisense Oligonucleotides
                     6.4.2.2. Nucleic Acid Aptamers
            6.4.3. Diagnostics
     6.5. Market Attractiveness by Application 

7. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By End User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast by End User, 2015–2025
            7.4.1. Biotechnology & Pharmaceutical Companies 
            7.4.2. Research Institutes  
            7.4.3. Diagnostic Laboratories 
     7.5. Market Attractiveness by End User 

8. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast by Region
            8.3.1. North America 
            8.3.2. Europe             
            8.3.3. Asia Pacific  
            8.3.4. Latin America  
            8.3.5. Middle East & Africa 
     8.4. Market Attractiveness by Country/Region

9. North America Oligonucleotide Synthesis Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market Value Forecast by Product Type, 2015–2025
            9.2.1. Reagents & Consumables
            9.2.2. Equipment
            9.2.3. Synthesized oligonucleotides
                     9.2.3.1. DNA Oligonucleotides  
                     9.2.3.2. RNA Oligonucleotides 
                     9.2.3.3. Others
     9.3. Market Value Forecast by Application, 2015–2025
            9.3.1. Research 
                     9.3.1.1. Polymerase Chain Reaction 
                     9.3.1.2. Next Generation Sequencing 
                     9.3.1.3. Others
            9.3.2. Therapeutics             
                     9.3.2.1. Antisense Oligonucleotides
                     9.3.2.2. Nucleic Acid Aptamers
            9.3.3. Diagnostics
     9.4. Market Value Forecast by End User, 2015–2025
            9.4.1. Biotechnology & Pharmaceutical Companies 
            9.4.2. Research Institutes  
            9.4.3. Diagnostic Laboratories 
     9.5. Market Value Forecast by Country, 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product Type 
            9.6.2. By Application 
            9.6.3. By End User 
            9.6.4. By Country

10. Europe Oligonucleotide Synthesis Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value Forecast by Product Type, 2015–2025
            10.2.1. Reagents & Consumables
            10.2.2. Equipment
            10.2.3. Synthesized oligonucleotides
                     10.2.3.1. DNA Oligonucleotides  
                     10.2.3.2. RNA Oligonucleotides 
                     10.2.3.3. Others
     10.3. Market Value Forecast by Application, 2015–2025
            10.3.1. Research 
                     10.3.1.1. Polymerase Chain Reaction 
                     10.3.1.2. Next Generation Sequencing 
                     10.3.1.3. Others
            10.3.2. Therapeutics 
                     10.3.2.1. Antisense Oligonucleotides
                     10.3.2.2. Nucleic Acid Aptamers
            10.3.3. Diagnostics
     10.4. Market Value Forecast by End User, 2015–2025
            10.4.1. Biotechnology & Pharmaceutical Companies 
            10.4.2. Research Institutes  
            10.4.3. Diagnostic Laboratories 
     10.5. Market Value Forecast by Country, 2015–2025
            10.5.1. Germany
            10.5.2. U.K.
            10.5.3. France
            10.5.4. Italy 
            10.5.5. Spain 
            10.5.6. Rest of Europe
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product Type 
            10.6.2. By Application 
            10.6.3. By End User 
            10.6.4. By Country

11. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market Value Forecast by Product Type, 2015–2025
            11.2.1. Reagents & Consumables
            11.2.2. Equipment
            11.2.3. Synthesized oligonucleotides
                     11.2.3.1. DNA Oligonucleotides  
                     11.2.3.2. RNA Oligonucleotides 
                     11.2.3.3. Others
     11.3. Market Value Forecast by Application, 2015–2025
            11.3.1. Research 
                     11.3.1.1. Polymerase Chain Reaction 
                     11.3.1.2. Next Generation Sequencing 
                     11.3.1.3. Others
            11.3.2. Therapeutics 
                     11.3.2.1. Antisense Oligonucleotides
                     11.3.2.2. Nucleic Acid Aptamers
            11.3.3. Diagnostics
     11.4. Market Value Forecast by End User, 2015–2025
            11.4.1. Biotechnology & Pharmaceutical Companies 
            11.4.2. Research Institutes  
            11.4.3. Diagnostic Laboratories 
     11.5. Market Value Forecast by Country, 2015–2025
            11.5.1. China
            11.5.2. India
            11.5.3. Japan
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia Pacific 
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product Type 
            11.6.2. By Application 
            11.6.3. By End User 
            11.6.4. By Country

12. Latin America Oligonucleotide Synthesis Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value Forecast by Product Type, 2015–2025
            12.2.1. Reagents & Consumables
            12.2.2. Equipment
            12.2.3. Synthesized oligonucleotides
                     12.2.3.1. DNA Oligonucleotides  
                     12.2.3.2. RNA Oligonucleotides 
                     12.2.3.3. Others
     12.3. Market Value Forecast by Application, 2015–2025
            12.3.1. Research 
                     12.3.1.1. Polymerase Chain Reaction 
                     12.3.1.2. Next Generation Sequencing 
                     12.3.1.3. Others
            12.3.2. Therapeutics 
                     12.3.2.1. Antisense Oligonucleotides
                     12.3.2.2. Nucleic Acid Aptamers
            12.3.3. Diagnostics
     12.4. Market Value Forecast by End User, 2015–2025
            12.4.1. Biotechnology & Pharmaceutical Companies
            12.4.2. Research Institutes  
            12.4.3. Diagnostic Laboratories 
     12.5. Market Value Forecast by Country, 2015–2025
            12.5.1. Brazil 
            12.5.2. Mexico
            12.5.3. Rest of Latin America 
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product Type 
            12.6.2. By Application 
            12.6.3. By End User 
            12.6.4. By Country

13. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
            13.1.3. Key Trends
     13.2. Market Value Forecast by Product Type, 2015–2025
            13.2.1. Reagents & Consumables
            13.2.2. Equipment
            13.2.3. Synthesized oligonucleotides
                     13.2.3.1. DNA Oligonucleotides  
                     13.2.3.2. RNA Oligonucleotides 
                     13.2.3.3. Others
     13.3. Market Value Forecast by Application, 2015–2025
            13.3.1. Research 
                     13.3.1.1. Polymerase Chain Reaction 
                     13.3.1.2. Next Generation Sequencing 
                     13.3.1.3. Others
            13.3.2. Therapeutics 
                     13.3.2.1. Antisense Oligonucleotides
                     13.3.2.2. Nucleic Acid Aptamers
            13.3.3. Diagnostics
     13.4. Market Value Forecast by End User, 2015–2025
            13.4.1. Biotechnology & Pharmaceutical Companies 
            13.4.2. Research Institutes  
            13.4.3. Diagnostic Laboratories 
     13.5. Market Value Forecast by Country, 2015–2025
            13.5.1. Saudi Arabia
            13.5.2. South Africa
            13.5.3. UAE
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product Type 
            13.6.2. By Application 
            13.6.3. By End User 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis by Company (2016)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. GE Healthcare
                     14.3.1.1. Financial Overview
                     14.3.1.2. Product Portfolio
                     14.3.1.3. SWOT Analysis
                     14.3.1.4. Strategic Overview
            14.3.2. Thermo Fisher Scientific 
                     14.3.2.1. Financial Overview
                     14.3.2.2. Product Portfolio
                     14.3.2.3. SWOT Analysis
                     14.3.2.4. Strategic Overview
            14.3.3. Agilent Technologies, Inc. 
                     14.3.3.1. Financial Overview
                     14.3.3.2. Product Portfolio
                     14.3.3.3. SWOT Analysis
                     14.3.3.4. Strategic Overview
            14.3.4. Merck KGaA 
                     14.3.4.1. Financial Overview
                     14.3.4.2. Product Portfolio
                     14.3.4.3. SWOT Analysis
                     14.3.4.4. Strategic Overview
            14.3.5. Integrated DNA Technologies, Inc.
                     14.3.5.1. Financial Overview
                     14.3.5.2. Product Portfolio
                     14.3.5.3. SWOT Analysis
                     14.3.5.4. Strategic Overview
            14.3.6. Kaneka Eurogentec S.A. (Kaneka Corporation) 
                     14.3.6.1. Financial Overview
                     14.3.6.2. Product Portfolio
                     14.3.6.3. SWOT Analysis
                     14.3.6.4. Strategic Overview
            14.3.7. TriLink BioTechnologies,LLC  (Maravai Life Sciences) 
                     14.3.7.1. Financial Overview
                     14.3.7.2. Product Portfolio
                     14.3.7.3. SWOT Analysis
                     14.3.7.4. Strategic Overview
            14.3.8. BioAutomation
                     14.3.8.1. Financial Overview
                     14.3.8.2. Product Portfolio
                     14.3.8.3. SWOT Analysis
                     14.3.8.4. Strategic Overview
            14.3.9. ATDBio Ltd.
                     14.3.9.1. Financial Overview
                     14.3.9.2. Product Portfolio
                     14.3.9.3. SWOT Analysis
                     14.3.9.4. Strategic Overview
            14.3.10. Gene Design, Inc. 
                     14.3.10.1. Financial Overview
                     14.3.10.2. Product Portfolio
                     14.3.10.3. SWOT Analysis
                     14.3.10.4. Strategic Overview
            14.3.11. Eurofins Genomics
                     14.3.11.1. Financial Overview
                     14.3.11.2. Product Portfolio
                     14.3.11.3. SWOT Analysis
                     14.3.11.4. Strategic Overview

List of Figures

Figure 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global oligonucleotide Synthesis Market Value Share, by Product Type (2016)
Figure 03: Global oligonucleotide Synthesis Market Value Share, by Application (2016)
Figure 04: Global oligonucleotide Synthesis Market Value Share, by End User (2016)
Figure 05: Global oligonucleotide Synthesis Market Value Share, by Region (2016)
Figure 06: Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 07: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2015–2025
Figure 08: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2015–2025
Figure 09: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2015–2025
Figure 10: Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
Figure 11: Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 12: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2015–2025
Figure 13: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
Figure 14: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
Figure 15: Global Oligonucleotide Synthesis Market Attractiveness, by Application 
Figure 16: Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 17: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2015–2025
Figure 18: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2015–2025
Figure 19: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
Figure 20: Global Oligonucleotide Synthesis Market Attractiveness, by End-user 
Figure 21: Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025 
Figure 22: Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2017–2025
Figure 23: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 24: North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 25: North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 26: North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 27: North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 28: North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 29: North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 30: North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 31: North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 32: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 33: Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 35: Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 36: Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 37: Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 38: Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 39: Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 40: Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 41: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 42: Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 43: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 44: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 45: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 46: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 47: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 48: Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 49: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 50: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 51: Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 53: Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 54: Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 55: Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 57: Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 59: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 60: Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 61: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 62: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 63: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 64: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 65: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 66: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 67: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 68: Global Oligonucleotide Synthesis Market Share, by Company, 2016

List of Tables

Table 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 03: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 05: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 06: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 11: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 13: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 14: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 17: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 18: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 20: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 21: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 24: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 25: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 26: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 27: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 28: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 29: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 31: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 32: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 35: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 36: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 38: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 39: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 41: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 42: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

Global Oligonucleotide Synthesis Market: Overview 

The oligonucleotide synthesis market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on genetics and genomics in the research and diagnostics applications, and rising application of oligonucleotides in therapeutics. 

The market overview section of the report comprises qualitative analysis of the overall oligonucleotide synthesis market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, market opportunity analysis for product for global as well as Asia Pacific has also been provided. The report also comprises applications of oligonucleotides, and PEST analysis.

Global Oligonucleotide Synthesis Market: Segmentation 

The global oligonucleotide synthesis market has been segmented on the basis of product, application and end user. The product segment is further segmented as, reagents & consumables, equipment, and synthesized oligonucleotide. The synthesized oligonucleotide segment is further segmented as, DNA oligonucleotides, RNA oligonucleotides, and others. Synthesized oligonucleotide segment accounted major share in 2016 of oligonucleotide synthesis market and expected to register high CAGR over forecast period. 

By application, the global oligonucleotide synthesis market is segmented as, research, therapeutics, and diagnostics. The research accounted major share in 2016 of oligonucleotide synthesis market. The segment is further segmented as, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NSG), and others. The therapeutic segment is fast growing segment by application over the forecast period owing to rising application of oligonucleotides in therapeutics. The segment is further segmented as antisense oligonucleotides, and nucleic acid aptamers. In market only few drugs are approved for therapeutic purpose and more than 100 are in various stages of clinical trials. 

On the basis of end user, the global oligonucleotide synthesis market is segmented as biotechnology & pharmaceutical companies, research institutes, and diagnostic laboratories. Research institutes segment accounted major share in 2016 by end user in global oligonucleotide synthesis market. The biotechnology and pharmaceutical companies segment is expected to register high CAGR over forecast period. Increasing research and development activities, and rising demand for new drug development for rare and genetic disease is expected to drive growth of biotechnology and pharmaceutical companies segment over the forecast period. Moreover, rising application of oligonucleotides in diagnostics is expected to drive the growth of diagnostics segment over the forecast period. 

The market for these product, application and end user has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence of major market players and their product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2015 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2025. 

Geographically, the oligonucleotide synthesis market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2015 to 2025, in terms of product, application and end user, along with the CAGR (%) for the forecast period 2017 to 2025. 

Global Oligonucleotide Synthesis Market: Competitive Analysis 

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global oligonucleotide synthesis market, in terms of percentage share in 2016 has been provided. The report concludes with the profiles of major players in the global oligonucleotide synthesis market such as Thermo Fisher Scientific, Sigma-Aldrich Corporation (a part of Merck KGaA), Integrated DNA Technologies, GE Healthcare, Kaneka Eurogentec S.A., Agilent Technologies, Applied Biosystems, BioAutomation, Eurofins Genomics, Gene Design, Inc. among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments. 

The global Oligonucleotide Synthesis market is segmented as given below: 

Oligonucleotide Synthesis Market, by Product Type

  • Reagents & Consumables
  • Equipment
  • Synthesized oligonucleotides
    • DNA oligonucleotides
    • RNA oligonucleotides
    • Others

Oligonucleotide Synthesis Market, by Application

  • Research
    • Polymerase Chain Reaction
    • Next Generation Sequencing
    • Others
  • Therapeutics
    • Antisense Oligonucleotides
    • Nucleic Acid Aptamers
  • Diagnostics

Oligonucleotide Synthesis Market, by End-users               

  • Biotechnology & Pharmaceutical Companies
  • Research Institutes
  • Diagnostic Laboratories

Global Oligonucleotide Synthesis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East & Africa


 
 
Back To Top